Journal of Controlled Release

Parkinson's & Movement disorders

First photoactive drug to fight Parkinson's disease

An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson's disease, according to the new article in Journal of Controlled Release.

Diseases, Conditions, Syndromes

New method could deliver DNA-based vaccines in pill form

A microscopic corn-and-shrimp cocktail could eventually make DNA-based vaccinations and cancer-treating gene therapies an easier pill to swallow, according to new research from the University of Nebraska-Lincoln.

Alzheimer's disease & dementia

The dawn of mRNA-based therapeutics for brain diseases

The progressive dementia suffered by patients with Alzheimer's disease (AD) affects millions of people globally each year and puts considerable strain on healthcare services. The mechanisms behind AD are not yet clear, and ...

Medical research

Regenerative bandage heals diabetic wounds faster

At some point in their lives, 15 percent of people with diabetes will develop a painful and hard-to-treat foot ulcer. Twenty-four percent of those affected will require a lower-leg amputation because of it. And, in some instances, ...

Oncology & Cancer

Boron carrier for targeted tumour therapy

Scientists at Tokyo Institute of Technology have developed a boron carrier for use in targeted radiation treatment for cancerous tumours. The carrier is based on a common blood plasma protein, meaning it can be tailored to ...

Cardiology

The vascular bypass revolution

Coronary or peripheral bypasses are the most frequently performed vascular operations. Although one million patients per year and around the world, undergo this intervention, its failure rate reaches 50%, because of poor ...

Oncology & Cancer

Cancer-killing proteins destroy tumor cells in bloodstream

Cornell researchers have discovered potent cancer-killing proteins that can travel by white blood cells to kill tumors in the bloodstream of mice with metastatic prostate cancer. The breakthrough study will be published Feb. ...

page 2 from 4